Collegium Pharmaceutical Stock Options
| COLL Stock | USD 33.40 0.27 0.80% |
Collegium Pharmaceutical's option chain provides insight into all available option contracts written on Collegium Pharmaceutical's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Collegium Pharmaceutical's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Collegium option contract.
In The Money vs. Out of Money Option Contracts on Collegium Pharmaceutical
Analyzing Collegium Pharmaceutical's in-the-money options over time can help investors to take a profitable long position in Collegium Pharmaceutical regardless of its overall volatility. This is especially true when Collegium Pharmaceutical's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Collegium Pharmaceutical's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Collegium Pharmaceutical's stock while costing only a fraction of its price.
Collegium Pharmaceutical's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.05 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Collegium Pharmaceutical option chain provides detailed quote and price information for the current Collegium Pharmaceutical option contracts. It shows all of Collegium Pharmaceutical's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Collegium Pharmaceutical option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Collegium Pharmaceutical's lending market. For example, when Collegium Pharmaceutical's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Collegium Pharmaceutical, he or she must hedge the risk by shorting Collegium Pharmaceutical stock over its option's life.
2024-05-17
The chart above shows Collegium Pharmaceutical's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Collegium Pharmaceutical's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Collegium Pharmaceutical's option, there is no secondary market available for investors to trade.
Collegium Pharmaceutical's stock options are financial instruments that give investors the right to buy or sell shares of Collegium Pharmaceutical common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Collegium stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Collegium Pharmaceutical's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. Please note that buying 'in-the-money' options on Collegium Pharmaceutical lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Collegium Pharmaceutical's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Collegium Pharmaceutical contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Collegium Stock moves the wrong way.
At this time, Collegium Pharmaceutical's Liabilities And Stockholders Equity is quite stable compared to the past year. Capital Stock is expected to rise to about 39 K this year, although the value of Total Stockholder Equity will most likely fall to about 127.6 M. Collegium Current Options Market Mood
Collegium Pharmaceutical's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Collegium Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Collegium Pharmaceutical's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Collegium Pharmaceutical's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Collegium Pharmaceutical's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Collegium contract
Base on the Rule 16, the options market is currently suggesting that Collegium Pharmaceutical will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-05-17 option contract. With Collegium Pharmaceutical trading at USD 33.4, that is roughly USD 0.0. If you think that the market is fully incorporating Collegium Pharmaceutical's daily price movement you should consider buying Collegium Pharmaceutical options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Collegium |
Purchasing Collegium Pharmaceutical options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Collegium calls. Remember, the seller must deliver Collegium Pharmaceutical stock to the call owner when a call is exercised.
Collegium Pharmaceutical Option Chain
When Collegium Pharmaceutical's strike price is surpassing the current stock price, the option contract against Collegium Pharmaceutical stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Collegium Pharmaceutical's option chain is a display of a range of information that helps investors for ways to trade options on Collegium. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Collegium. It also shows strike prices and maturity days for a Collegium Pharmaceutical against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $17.5 | 0.9759 | 0.0046 | 0 | 2024-05-17 | 14.1 - 18.5 | 0.0 | In |
Call | 2024-05-17 CALL at $20.0 | 0.9286 | 0.0098 | 0 | 2024-05-17 | 12.4 - 16.0 | 0.0 | In |
Call | 2024-05-17 CALL at $22.5 | 0.934 | 0.0128 | 0 | 2024-05-17 | 9.5 - 13.5 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.9177 | 0.0193 | 0 | 2024-05-17 | 7.0 - 11.0 | 0.0 | In |
Call | 2024-05-17 CALL at $30.0 | 0.8842 | 0.0574 | 2 | 2024-05-17 | 1.75 - 6.0 | 3.9 | In |
Put | 2024-05-17 PUT at $40.0 | -0.9477 | 0.0309 | 3 | 2024-05-17 | 4.3 - 8.5 | 5.43 | In |
Put | 2024-05-17 PUT at $45.0 | -0.9459 | 0.019 | 0 | 2024-05-17 | 9.6 - 13.3 | 5.33 | In |
Put | 2024-05-17 PUT at $50.0 | -0.9697 | 0.0102 | 0 | 2024-05-17 | 14.3 - 18.5 | 0.0 | In |
Put | 2024-05-17 PUT at $55.0 | -0.7567 | 0.0181 | 0 | 2024-05-17 | 19.2 - 23.3 | 0.0 | In |
Collegium Pharmaceutical Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Collegium Pharmaceutical Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
Collegium Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Collegium Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Collegium Pharmaceutical Corporate Management
Elected by the shareholders, the Collegium Pharmaceutical's board of directors comprises two types of representatives: Collegium Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Collegium. The board's role is to monitor Collegium Pharmaceutical's management team and ensure that shareholders' interests are well served. Collegium Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Collegium Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD FAAFP | Executive Officer | Profile | |
| Bart Dunn | Executive Development | Profile | |
| Scott Sudduth | Head Operations | Profile | |
| Christopher MD | Vice Relations | Profile | |
| RPh Pharm | CoFounder Chairman | Profile | |
| Marlo Manning | Head HR | Profile |
Already Invested in Collegium Pharmaceutical?
The danger of trading Collegium Pharmaceutical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Collegium Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Collegium Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Collegium Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 2.51 | Revenue Per Share 17.054 | Quarterly Revenue Growth 0.001 | Return On Assets 0.1056 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.